Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.6.2.4 extracted from

  • Lehr, M.; Fabian, J.; Hanekamp, W.
    Involvement of microsomal NADPH-cytochrome P450 reductase in metabolic reduction of drug ketones (2015), Biopharm. Drug Dispos., 36, 398-404 .
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
alpha-lipoic acid 17% inhibition at 5.0 mM Homo sapiens
Ethacrynic acid 64% inhibition at 1.0 mM Homo sapiens
menadione 85% inhibition at 0.2 mM Homo sapiens
additional information no significant inhibition by diphenyleneiodonium chloride, flufenamic acid, and 18beta-glycyrrhetinic acid Homo sapiens
phenolphthaleine 13% inhibition at 0.02 mM Homo sapiens
quercetin 48% inhibition at 0.2 mM Homo sapiens

Localization

Localization Comment Organism GeneOntology No. Textmining
microsome
-
Homo sapiens
-
-

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
NADPH + H+ + 1-[3-(4-phenoxyphenoxy)-2-oxopropyl]indole-5-carboxylic acid
-
Homo sapiens NADP+ + 1-[2-hydroxy-3-(4-phenoxyphenoxy)propyl]indole-5-carboxylic acid
-
?
NADPH + H+ + daunorubicin
-
Homo sapiens NADP+ + ?
-
?
NADPH + H+ + haloperidol
-
Homo sapiens NADP+ + ?
-
?

Synonyms

Synonyms Comment Organism
NADPH-CYP450 reductase
-
Homo sapiens
NADPH-cytochrome P450 reductase
-
Homo sapiens

Cofactor

Cofactor Comment Organism Structure
FAD
-
Homo sapiens
FMN
-
Homo sapiens